Showing results (61-70 of 90) with videos related to
Sort By:
Pageof 9
BMC Cancer|January 19, 2012
A common variant of the MACC1 gene is significantly associated with overall survival in colorectal cancer patientsAlois H Lang, Simone Geller-Rhomberg, Thomas Winder, et al.Journal of Diabetes and Its Complications|October 2, 2021
Single and joint impact of type 2 diabetes and of congestive heart failure on albuminuriaChristoph H Saely, Maximilian Maechler, Alexander Vonbank, et al.Data in Brief|May 2, 2022
Data on the association of serum glypican-4 with future major adverse cardiovascular events and mortality in patients undergoing coronary angiographyAxel Muendlein, Eva Maria Brandtner, Andreas Leiherer, et al.Journal of Diabetes and Its Complications|September 4, 2020
Type 2 diabetes mellitus is a strong predictor of LDL cholesterol target achievement in patients with peripheral artery diseaseChristoph H Saely, Simon Sternbauer, Alexander Vonbank, et al.The Journal of Clinical Endocrinology and Metabolism|August 14, 2020
Serum Parathyroid Hormone Predicts Mortality in Coronary Angiography Patients with Type 2 DiabetesEva Maria Brandtner, Axel Muendlein, Andreas Leiherer, et al.Atherosclerosis|June 27, 2025
Serum leucine-rich α-2 glycoprotein 1 predicts 10-year mortality and vascular events in coronary angiography patientsAxel Muendlein, Andreas Leiherer, Eva Maria Brandtner, et al.Clinical Biochemistry|October 16, 2023
Circulating glypican-4 is a new predictor of all-cause mortality in patients with heart failureAxel Muendlein, Christine Heinzle, Andreas Leiherer, et al.Thrombosis and Haemostasis|March 6, 2007
The -11377 C>G promoter variant of the adiponectin gene, prevalence of coronary atherosclerosis, and incidence of vascular events in menGuenter Hoefle, Axel Muendlein, Christoph H Saely, et al.European Journal of Clinical Investigation|June 2, 2026
Circulating Human Epididymis Protein 4 Predicts 10-Year Mortality and Major Adverse Cardiovascular Events in Patients With Peripheral Artery DiseaseAxel Muendlein, Christine Heinzle, Kathrin Geiger, et al.Kidney360|March 10, 2025
Evaluation of Circulating GPC4 in Patients with End-Stage Kidney DiseaseAxel Muendlein, Eva Maria Brandtner, Judith Schimpf, et al.Pageof 9